MoneyThe story, in brief
Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery
$2.1B. That's what Isomorphic Labs just raised—the biggest bet yet that AI can discover drugs faster than humans.
The KeyNews take
Why it matters
Isomorphic's massive fundraise signals investor confidence in AI-driven drug discovery as a path to clinical impact, but the company's secrecy on pipeline could indicate either breakthrough science or execution risk that markets haven't priced in yet.
The key facts
5 to knowIsomorphic Labs raised $2.1B
Largest funding round for an AI drug discovery company
Isomorphic formed as Alphabet company in 2021
Company remains tight-lipped on clinical pipeline
Published May 2026
Go to the source
Forbes Innovationforbes.com
Publisher excerpt: Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.